- Home
- NDMO vs PLRX Comparison
NDMO vs PLRX Comparison
Compare NDMO & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDMO
- PLRX
- Stock Information
- Founded
- NDMO 2019
- PLRX 2015
- Country
- NDMO United States
- PLRX United States
- Employees
- NDMO N/A
- PLRX N/A
- Industry
- NDMO Trusts Except Educational Religious and Charitable
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- NDMO Finance
- PLRX Health Care
- Exchange
- NDMO Nasdaq
- PLRX Nasdaq
- Market Cap
- NDMO N/A
- PLRX 84.7M
- IPO Year
- NDMO N/A
- PLRX 2020
- Fundamental
- Price
- NDMO $10.21
- PLRX $1.20
- Analyst Decision
- NDMO
- PLRX Hold
- Analyst Count
- NDMO 0
- PLRX 10
- Target Price
- NDMO N/A
- PLRX $9.79
- AVG Volume (30 Days)
- NDMO 218.6K
- PLRX 1.5M
- Earning Date
- NDMO 01-01-0001
- PLRX 08-06-2025
- Dividend Yield
- NDMO 6.75%
- PLRX N/A
- EPS Growth
- NDMO N/A
- PLRX N/A
- EPS
- NDMO N/A
- PLRX N/A
- Revenue
- NDMO N/A
- PLRX N/A
- Revenue This Year
- NDMO N/A
- PLRX N/A
- Revenue Next Year
- NDMO N/A
- PLRX N/A
- P/E Ratio
- NDMO N/A
- PLRX N/A
- Revenue Growth
- NDMO N/A
- PLRX N/A
- 52 Week Low
- NDMO $8.99
- PLRX $1.10
- 52 Week High
- NDMO $11.24
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- NDMO 60.93
- PLRX 37.92
- Support Level
- NDMO $9.95
- PLRX $1.13
- Resistance Level
- NDMO $10.04
- PLRX $1.43
- Average True Range (ATR)
- NDMO 0.10
- PLRX 0.11
- MACD
- NDMO 0.01
- PLRX -0.02
- Stochastic Oscillator
- NDMO 65.00
- PLRX 17.11
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.